Document is current

Article History

First Online: 9 April 2018

Compliance with Ethical Standards

:

: The analyses and studies presented in this report were sponsored by Forest Research Institute, an Allergan affiliate. The sponsor was involved in conducting the analyses, interpreting the results, and the decision to submit this manuscript for publication.

: R. Findling receives or has received research support, has acted as a consultant and/or served on a speaker’s bureau for Aevi, Akili, Alcobra, Amerex, American Academy of Child & Adolescent Psychiatry, American Psychiatric Press, Bracket, Epharma Solutions, Forest, Genentech, Guilford Press, Ironshore, Johns Hopkins University Press, KemPharm, Lundbeck, Merck, NIH, Neurim, Nuvelution, Otsuka, PCORI, Pfizer, Physicians Postgraduate Press, Purdue, Roche, Sage, Shire, Sunovion, Supernus Pharmaceuticals, Syneurx, Teva, Tris, TouchPoint, Validus, and WebMD. S. Durgam, C. Chen, R. Migliore, C. Prakash, and J. Edwards are full-time employees of Allergan.

: The study was approved by an institutional review board at each study center involved in the study (n = 56) and conducted in compliance with the Declaration of Helsinki and ICH Guidances on General Considerations for Clinical Trials and Good Clinical Practice.

: Informed consent was obtained from all individual participants included in the study. Written permission was obtained from parents or legal guardians in accordance with appropriate local laws, where applicable.